Search
Search Results
##search.searchResults.foundPlural##
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1741PDF: 1294HTML: 512 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3663PDF: 2574HTML: 1556 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1173PDF: 525HTML: 381 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7766PDF: 2463HTML: 2103Table 1.: 234Table 2.: 244Table 3.: 226Table 4.: 219 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2179PDF: 854HTML: 1648Figure 1: 567 -
-
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2703PDF: 981HTML: 3725 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4155PDF: 1276HTML: 2112Table 1: 211 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1598PDF: 807HTML: 1527Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 190 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3401PDF: 1357HTML: 6336 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1304PDF: 539HTML: 23120 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
1935PDF: 1169HTML: 1776 -
Common parasite with uncommon associations
1542PDF: 687HTML: 1853 -
-
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1483PDF: 1359HTML: 111 -
Osteolytic bone lesions – A rare presentation of AML M6.
2039PDF: 1141HTML: 7980Untitled: 215 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
977PDF: 538HTML: 218 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1642PDF: 1016HTML: 375 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3657PDF: 1567HTML: 4495CoverLetter: 196Figure1: 209 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5258PDF: 1364HTML: 2863Cover letter: 216 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2747PDF: 972HTML: 621 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2196PDF: 1030HTML: 4089Cover Letter: 233Figure 1: 244Figure 2: 241Table 1: 215 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1878PDF: 840HTML: 10345Figures 1,2,3: 205 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2932PDF: 1134HTML: 453Preferred Reviewers: 221







